Buy, hold, sell: BHP, CSL, and Endeavour shares

Let's see if analysts are bullish, bearish, or something in-between with these shares.

| More on:
Young businesswoman sitting in kitchen and working on laptop.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Wondering which popular ASX shares to buy, hold, or sell? Let's take a look at what analysts are saying about three popular options, courtesy of The Bull.

Here's what they are recommending to their clients:

BHP Group Ltd (ASX: BHP)

This mining giant's shares could be fully valued now following a strong run according to analysts at Morgans. As a result, the broker has put a hold rating on the Big Australian.

It thinks that investors should hold onto BHP's shares for the income but wait for a better entry point before increasing positions. The broker explains:

BHP remains a high quality diversified miner. The stock has performed well, with the price increasing from $34.16 on April 9, 2025 to trade at $51.39 on January 29, 2026. While capital discipline and dividend yield remain attractive, there isn't a compelling catalyst to add to portfolios at current levels, in our view. We suggest investors retain exposure for income and longer term portfolio balance, and wait for a potentially better entry point before increasing weight.

CSL Ltd (ASX: CSL)

Morgans thinks the risk-reward on offer with this biopharmaceutical giant's shares is attractive at current levels. As a result, it has named CSL shares as a buy.

The broker highlights that its current valuation is notably lower than long-term averages, which bodes well for buyers. It said:

This biopharmaceutical giant offers a stronger risk/reward profile after a period of share price underperformance. Plasma collections are rising, costs are normalising and earnings momentum is improving. Recovery at CSL Behring, a blood products division, remains on track and the influenza vaccination division Seqirus continues to provide defensive earnings. The current valuation sits well below long term averages despite fundamental improvement. This sets up an attractive long term capital growth story. Catalysts for a share price re-rating include an earnings recovery and margin expansion.

Endeavour Group Ltd (ASX: EDV)

The team at Capital Wealth is tipping this drinks giant as a hold this week.

It thinks that investors should keep their powder dry until it has released its updates in the coming months. It said:

Endeavour operates liquor outlets, hotels and gaming facilities. The company expects earnings before interest and tax (EBIT) of between $555 million and $566 million before significant items of $45 million in the first half of fiscal year 2026. Preliminary unaudited retail EBIT of between $323 million and $328 million reflects margin pressure from discounting that lifted Dan Murphy's and BWS sales by 0.7 per cent to $5.404 billion.

Hotel sales rose 4.4 per cent to $1.2 billion. Despite hotel strength and softer earnings, we continue to hold EDV pending its March and April updates as the company offers defensive attributes and could rebound on signs of successfully executing its strategy under new chief executive Jayne Hrdlicka.

More on Broker Notes

Red buy button on an apple keyboard with a finger on it representing asx tech shares to buy today
Broker Notes

3 ASX 200 shares to buy: experts

Experts reveal three ASX 200 shares with buy ratings, and why they recommend investing in them.

Read more »

Two mining workers on a laptop at a mine site.
Resources Shares

3 ASX mining shares to sell: experts

ASX mining shares are a popular investment amid rising commodity prices, but experts recommend selling these producers.

Read more »

Two businesspeople walk together in an office, smiling as they enjoy a good business relationship.
Broker Notes

This ASX 200 share could rise 30% and pay a 5% dividend yield

Bell Potter sees this stock as a top pick for Aussie investors in 2026.

Read more »

A female broker in a red jacket whispers in the ear of a man who has a surprised look on his face as she explains which two ASX 200 shares should do well in today's volatile climate
Broker Notes

Buy, hold, sell: CAR, REA, and Life360 shares

Analysts have given their verdict on three popular stocks this week.

Read more »

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Broker Notes

Bell Potter names the best ASX shares to buy in February

These stocks have been named as best buys by the broker this month. Let's see why.

Read more »

Boy holding chalk board depicting buy and sell options for ASX shares.
Broker Notes

Buy, hold, sell: Wesfarmers, Woolworths, CSL shares

Expert reveals his ratings on three of the biggest names on the ASX 200.

Read more »

A smiling woman holds a Facebook like sign above her head.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to buy these shares.

Read more »

A man holds his head in his hands, despairing at the bad result he's reading on his computer.
Broker Notes

Experts name NAB and these ASX 200 shares as sells

Experts have turned bearish on these big names. Let's see why.

Read more »